| Literature DB >> 18299036 |
Abstract
This article focuses on the most important diseases of dairy calves and heifers and presents clinical approaches that can improve detection, diagnosis, and treatment of herd-based problems. A systematic herd investigation strategy is pivotal to define the problems, understand important risk factors, develop a plan, and make recommendations for disease management accurately. A review of records, colostrum and feeding routines, housing and bedding management, routine procedures, vaccination, and treatment protocols begins the investigation and determines which diagnostic procedures and testing strategies are most useful. Disease management is most effective when the problem source is well defined and the exposure can be limited, calf immunity can be enhanced, or a combination of both. Screening examinations performed regularly or done at strategic time points improves detection of disease, can be used to monitor treatment outcomes, and can avoid disease outbreaks.Entities:
Mesh:
Year: 2008 PMID: 18299036 PMCID: PMC7135781 DOI: 10.1016/j.cvfa.2007.10.003
Source DB: PubMed Journal: Vet Clin North Am Food Anim Pract ISSN: 0749-0720 Impact factor: 3.357
Calf health records that elucidate age of onset, morbidity, and mortality
| Calf ID | Calf birth date | Illness 0–48 hours (√) | Illness 48 hours–5 days (√) | Illness 5–14 days (√) | Illness 14 days–weaning (√) | Treated calf more than 1 episode of illness (√) | Recovered (R) or died/culled (D) |
|---|---|---|---|---|---|---|---|
| 3148 | (√) | R | |||||
| 3150 | (√) | D |
Fecal examination and analysis from a calf diarrhea investigation with typical day of onset at 9 days
| Animal ID | Age or date of birth (d) | Fecal score | EM for virus | Smear for | Identified or treated (√) | |
|---|---|---|---|---|---|---|
| 7200 | 10 | 2 | Negative | Negative | Negative | |
| 7202 | 9 | 0 | Negative | Positive | Negative | |
| 7203 | 9 | 2B | Coronavirus | Positive | Negative | |
| 7204 | 9 | 2 | Negative | Positive | ||
| 7207 | 8 | 1 | Negative | Positive | Negative | |
| 7209 | 8 | 3 | Rotavirus | Positive | Negative | √ |
| 7210 | 7 | 1 | Negative | Positive | Negative |
Where fecal score is 0 = normal consistency; 1 = semiformed or pasty; 2 = loose but enough consistency to remain on bedding; 3 = watery feces that sift through bedding material; B = blood is present.
Bedding sample results from a dairy with diarrhea in 5-day-old calves
| Sample source | Coliforms (colonies/mL) | Total colonies (colonies/mL) | |
|---|---|---|---|
| Maternity pen | 1000 | 576,000 | Negative |
| Empty maternity hutch | 35,000 | 36,875 | Negative |
| Clean hutch | 750 | 11,500 | Negative |
| 3-day occupied hutch | 1500 | 577,500 | Negative |
| Truck | 6,900,000 | 6,921,750 | |
| Goal for clean pen | <1000 | <5000 | Negative |
| Goal for occupied pen | <500,000 | <2,000,000 | Negative |
Bulk tank milk culture results from unpasteurized milk and milk replacer samples from dairies with calf diarrhea problems
| Range (cfu/mL) | Goal (cfu/mL) | |
|---|---|---|
| Total count | 1500–>15,000,000 | <10,000 |
| Fecal coliforms | 0–>15,000,000 | 0 |
| Other gram-negative bacteria | 0–>15,000,000 | <5000 |
| 0–80,000 | <5000 | |
| Coagulase-negative | 0–95,000 | <5000 |
| 0–40,000 | 0 | |
| Other bacteria | 0–50,000 (with probiotics) | <5000 if no probiotics are added |
Respiratory disease evaluation in group pens on a dairy with pneumonia
| Group pen: % with abnormal (score 2 or 3) scores (goal: 10% or fewer in any category) | |||||||
|---|---|---|---|---|---|---|---|
| Group pen ID | Age range (wk) | Number of calves | % Nasal discharge | % Coughing | % Eyes | % Ears | Comments |
| 21A | 13–14 | 7 | 0 | 14.3 | 42.9 | 14.3 | Respiratory disease |
| 21B | 11 | 5 | 20 | 0 | 0 | 20 | Two calves |
| 21C | 11 | 5 | 0 | 20 | 0 | 0 | Calf #4076 |
| 21D | 11–12 | 7 | 0 | 14.3 | 28.6 | 57.1 | Respiratory disease |
| 21E | 12 | 8 | 14.3 | 25 | 25 | 25 | Respiratory disease |
| 21F | 12–13 | 8 | 25 | 0 | 37.5 | 0 | Conjunctivitis |
| 21G&H | 14–16 | 17 | 6.3 | 25 | 25 | 12.5 | Respiratory disease |
| 22J | 16–18 | 20 | 0 | 10 | 10 | 5 | Watch this pen |
| 22K | 18–20 | 22 | 9.1 | 30 | 9.1 | 30 | Respiratory disease |
| 22L | 23–25 | 21 | 19 | 9.5 | 9.5 | 9.5 | Watch this pen |
| 22M | 20–23 | 20 | 15 | 35 | 35 | 20 | Respiratory disease |
Nasal swab bacterial isolates and antibiotic susceptibilities
| Antibiotic | Histophilus somnus | ||
|---|---|---|---|
| Amp/amoxicillin | Sensitive | Resistant | Resistant |
| Ceftiofur | Sensitive | Sensitive | Sensitive |
| Florfenicol | Sensitive | Sensitive | Sensitive |
| Spectinomycin | Sensitive | Sensitive | Incomplete |
| Tetracycline | Resistant | Resistant | Incomplete |
| Trimethoprim-sulfonamide | Sensitive | Sensitive | Sensitive |
| Tilmicosin | Sensitive | Sensitive | Sensitive |
| Tulathromycin | Sensitive | Sensitive | Sensitive |